Michael Grosso

Transmyocardial laser therapy: a strategic approach.

Fluorescence spectroscopy and imaging of myocardial apoptosis.

Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.

Use of PER977 to reverse the anticoagulant effect of edoxaban.

Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate.

A review of antithrombotic therapy and the rationale and design of the randomized edoxaban in patients with peripheral artery disease (ePAD) trial adding edoxaban or clopidogrel to aspirin after femoropopliteal endovascular intervention.